1-13 of 13
Anne-Lise Børresen-Dale
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer

Laxmi Silwal-Pandit, Silje Nord, Hedda von der Lippe Gythfeldt, Elen K. Møller, Thomas Fleischer, Einar Rødland, Marit Krohn, Elin Borgen, Øystein Garred, Tone Olsen, Phuong Vu, Helle Skjerven, Anne Fangberget, Marit M. Holmen, Ellen Schlitchting, Elisabeth Wille, Mette Nordberg Stokke, Hans Kristian Moen Vollan, Vessela Kristensen, Anita Langerød, Steinar Lundgren, Erik Wist, Bjørn Naume, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Olav Engebraaten
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (16): 4662–4670.
https://doi.org/10.1158/1078-0432.CCR-17-0160
Published: 15 August 2017
View articletitled, The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
Open the PDF for The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PL1-1: Genomic architecture characterizes tumor progression paths and fate in breast cancer patients

Anne-Lise Børresen-Dale
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): PL1-1.
https://doi.org/10.1158/1078-0432.TCME10-PL1-1
Published: 02 February 2016
View articletitled, Abstract PL1-1: Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
Journal Articles

Abstract B43: Gene expression in breast tissue associated with mammographic density in healthy women

Vilde D. Haakensen, Margarethe Biong, Ole Christian Lingjærde, Marit Muri Holmen, Jan Ole Frantzen, Chen Ying, Dina Navjord, Linda Romundstad, Hiroko K. Solvang, Kristensen N. Vessela, Giske Ursin, Anne-Lise Børresen-Dale, Åslaug Helland
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): B43.
https://doi.org/10.1158/1078-0432.TCME10-B43
Published: 02 February 2016
View articletitled, Abstract B43: Gene expression in breast tissue associated with mammographic density in healthy women
Journal Articles

A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients

Kristine Kleivi Sahlberg, Giulia Bottai, Bjørn Naume, Barbara Burwinkel, George A. Calin, Anne-Lise Børresen-Dale, Libero Santarpia
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1207–1214.
https://doi.org/10.1158/1078-0432.CCR-14-2011
Published: 01 March 2015
View articletitled, A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
Open the PDF for A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients in another window
Includes: Supplementary data
Journal Articles

DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2/p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast Tumors

Jovana Klajic, Florence Busato, Hege Edvardsen, Nizar Touleimat, Thomas Fleischer, Ida Bukholm, Anne-Lise Børresen-Dale, Per Eystein Lønning, Jörg Tost, Vessela N. Kristensen
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (24): 6357–6366.
https://doi.org/10.1158/1078-0432.CCR-14-0297
Published: 14 December 2014
View articletitled, DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2/p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast Tumors
Open the PDF for DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2/p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast Tumors in another window
Includes: Supplementary data
Journal Articles

Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc Cohort

Trine Tramm, Hayat Mohammed, Simen Myhre, Marianne Kyndi, Jan Alsner, Anne-Lise Børresen-Dale, Therese Sørlie, Arnoldo Frigessi, Jens Overgaard
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (20): 5272–5280.
https://doi.org/10.1158/1078-0432.CCR-14-0458
Published: 14 October 2014
View articletitled, Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc Cohort
Open the PDF for Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc Cohort in another window
Includes: Supplementary data
Journal Articles

TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance

Laxmi Silwal-Pandit, Hans Kristian Moen Vollan, Suet-Feung Chin, Oscar M. Rueda, Steven McKinney, Tomo Osako, David A. Quigley, Vessela N. Kristensen, Samuel Aparicio, Anne-Lise Børresen-Dale, Carlos Caldas, Anita Langerød
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (13): 3569–3580.
https://doi.org/10.1158/1078-0432.CCR-13-2943
Published: 30 June 2014
View articletitled, TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
Open the PDF for TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance in another window
Includes: Supplementary data
Journal Articles

Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications

Vessela N. Kristensen, Therese Sørlie, Jurgen Geisler, Anita Langerød, Noriko Yoshimura, Rolf Kåresen, Nobuhiro Harada, P.E. Lønning, Anne-Lise Børresen-Dale
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 878s–883s.
https://doi.org/10.1158/1078-0432.878s.11.2
Published: 01 September 2009
View articletitled, Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications
Open the PDF for Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications in another window
Journal Articles

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Sharon A. Glynn, Brenda J. Boersma, Tiffany M. Howe, Hege Edvardsen, Stephanie B. Geisler, Julie E. Goodman, Lisa A. Ridnour, Per E. Lønning, Anne-Lise Børresen-Dale, Bjorn Naume, Vessela N. Kristensen, Stephen J. Chanock, David A. Wink, Stefan Ambs
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (12): 4165–4173.
https://doi.org/10.1158/1078-0432.CCR-09-0119
Published: 15 June 2009
View articletitled, A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide
Open the PDF for A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide in another window
Includes: Supplementary data
Journal Articles

Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer

Roshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, Mark Carey, Ju-Seog Lee, Jens Overgaard, Jan Alsner, Katherine Stemke-Hale, Ana Lluch, Richard M. Neve, Wen Lin Kuo, Therese Sorlie, Aysegul Sahin, Vicente Valero, Khandan Keyomarsi, Joe W. Gray, Anne-Lise Borresen-Dale, Gordon B. Mills, Bryan T. Hennessy
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (11): 3654–3662.
https://doi.org/10.1158/1078-0432.CCR-08-3293
Published: 01 June 2009
View articletitled, Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer
Open the PDF for Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

The Novel p21 Polymorphism p21G251A Is Associated with Locally Advanced Breast Cancer

Vidar Staalesen, Stian Knappskog, Ranjan Chrisanthar, Silje H. Nordgard, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Inger Torhild Gram, Vessela N. Kristensen, Anne-Lise Børresen-Dale, Johan Richard Lillehaug, Per Eystein Lønning
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6000–6004.
https://doi.org/10.1158/1078-0432.CCR-05-2822
Published: 24 October 2006
View articletitled, The Novel p21 Polymorphism p21G251A Is Associated with Locally Advanced Breast Cancer
Open the PDF for The Novel p21 Polymorphism p21G251A Is Associated with Locally Advanced Breast Cancer in another window
Journal Articles

Interaction between p53 Staining and High-Dose Chemotherapy in Breast Cancer

Per Eystein Lønning, Anne-Lise Børresen-Dale
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2289.
https://doi.org/10.1158/1078-0432.CCR-06-0129
Published: 11 April 2006
View articletitled, Interaction between p53 Staining and High-Dose Chemotherapy in Breast Cancer
Open the PDF for Interaction between p53 Staining and High-Dose Chemotherapy in Breast Cancer in another window
Journal Articles

TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer

Stephanie Geisler, Anne-Lise Børresen-Dale, Hilde Johnsen, Turid Aas, Jürgen Geisler, Lars Andreas Akslen, Gun Anker, Per Eystein Lønning
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5582–5588.
Published: 03 December 2003
View articletitled, TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer
Open the PDF for TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer in another window